Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Oncotelic Therapeutics, Inc.

OTC: OTLC · Life Sciences · 4 alerts · CIK 908259

Share price
$0.0134Close, Nov 16
Market cap
$6.13M
Shares outstanding
457.51MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oncotelic Therapeutics, Inc. filings on SEC EDGAR ↗

4:31 PM ET 10-Q
Financial Results

Oncotelic Therapeutics Q3 2026 Results: Net Loss of $1.11M, Loss Widens

Oncotelic Therapeutics reported a net loss of $2.92 million for the nine months ended September 30, 2026, compared to a loss of $1.07 million in the prior year period. The company's balance sheet is dominated by a $388 million investment in GMP Bio at fair value, while it continues to manage significant debt obligations and a working capital deficit.

Key figure
Net loss $1.11M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.